Phase II Study of PARP Inhibitor Olaparib and IV Ascorbate in Castration Resistant Prostate Cancer
Clinical trial NCT05501548 · TERMINATED
Trial details
- NCT number
- NCT05501548
- Sponsor
- Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-06-30
- Primary completion
- 2024-10-14
- Enrollment
- 4
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.